Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma by Lichang Huang, Yujie Xu, Na Liu, Hailong Chen, Zichao Wu, Qijiong Li, Minqiang Lu, Wei Wei, Yaojun Zhang, Minshan Chen, Li Xu, Ming Shi, Zhicheng Lai

Get full text

Liver protection of CACA technical guidelines for holistic integrative management of cancer by Ningning Zhang, Lungen Lu, Baoshan Cao, Yanjing Gao, Feng Han, Liangping Li, Qijiong Li, Shuchen Li, Xiaowu Li, Jingfeng Liu, Yefu Liu, Yingqian Lv, Yongzhan Nie, Xizhong Shen, Dongde Wu, Qiang Wu, Jun Xu, Liping Yao, Ning Zhang, Yuzheng Zhuge, Xiubao Ren, De’an Tian, Guohong Han, Wei Lu, Oncology Hepatology Committee of China Anti-Cancer Association

Get full text